Catalyst Wire Dossier Catalyst Wire Dossier

Cabenuva (cabotegravir + rilpivirine)

cabotegravir and rilpivirine · ViiV Healthcare
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cabenuva (cabotegravir + rilpivirine), covering 2025-08-20 to 2025-08-20. Get the full timeline:

Most recent: Clinical Trial Update: The Quality of Life and Viral Control Effect of AIDS Patients After Long-acting Injection of Cabotegravir and Rilpivirine

See pricing